Cargando…

Functional Differences Between EBV- and CMV-Specific CD8(+) T cells Demonstrate Heterogeneity of T cell Dysfunction in CLL

Acquired T cell dysfunction is a hallmark of chronic lymphocytic leukemia (CLL), and is linked to an increased risk of infections, but also reduced immune surveillance and disappointing responses to autologous T cell-based immunotherapy. The mechanisms of T cell dysfunction in CLL are not well under...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hofland, Tom, de Weerdt, Iris, Endstra, Sanne, Jongejan, Aldo, Platenkamp, Laura, Remmerswaal, Ester B.M., Moerland, Perry D., ten Berge, Ineke J.M., Levin, Mark-David, Kater, Arnon P., Tonino, Sanne H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162091/ https://www.ncbi.nlm.nih.gov/pubmed/32309780 http://dx.doi.org/10.1097/HS9.0000000000000337

Ejemplares similares

Natural Killer Cell Hypo-responsiveness in Chronic Lymphocytic Leukemia can be Circumvented In Vitro by Adequate Activating Signaling
por: Hofland, Tom, et al.
Publicado: (2019)

Engaging Cytotoxic T and NK Cells for Immunotherapy in Chronic Lymphocytic Leukemia
por: Hofland, Tom, et al.
Publicado: (2019)

Human CXCR5(+)PD‐1(+) CD8 T cells in healthy individuals and patients with hematologic malignancies
por: Hofland, Tom, et al.
Publicado: (2020)

Clinical consequences of primary CMV infection after renal transplantation: a case–control study
por: Singh, Ramandeep, et al.
Publicado: (2020)

In Vitro 3D Spheroid Culture System Displays Sustained T Cell-dependent CLL Proliferation and Survival
por: Haselager, Marco V., et al.
Publicado: (2023)

Overcoming the Hurdles of Autologous T-Cell-Based Therapies in B-Cell Non-Hodgkin Lymphoma
por: van Bruggen, Jaco A. C., et al.
Publicado: (2020)

Correction: van Bruggen et al. Overcoming the Hurdles of Autologous T-Cell-Based Therapies in B-Cell Non-Hodgkin Lymphoma. Cancers 2020, 12, 3837
por: van Bruggen, Jaco A. C., et al.
Publicado: (2021)

The prevalence of EBV and CMV DNA in epithelial ovarian cancer
por: Ingerslev, Kasper, et al.
Publicado: (2019)

S291: LONG-TERM SAFETY AND EFFICACY OF CMV/EBV-SPECIFIC T CELLS FOR CMV AND EBV CO-REACTIVATION AFTER HAPLOIDENTICAL STEM CELL TRANSPLANTATION
por: Xuying, Pei, et al.
Publicado: (2023)

Combining novel agents in chronic lymphocytic leukemia: Greater than the sum of its parts?
por: de Weerdt, Iris, et al.
Publicado: (2019)

Co-Occurrence of EBV-Positive Mucocutaneous Ulcer (EBV-MCU) and CLL/SLL in the Head and Neck Region
por: Bott, Patricia, et al.
Publicado: (2022)

CMV and EBV Co-Infection in HIV-Infected Children: Infection Rates and Analysis of Differential Expression of Cytokines in HIV Mono- and HIV–CMV–EBV Co-Infected Groups
por: Nazim, Fizza, et al.
Publicado: (2022)

Congenital and Postnatal CMV and EBV Acquisition in HIV-Infected Zimbabwean Infants
por: Gumbo, Hlanai, et al.
Publicado: (2014)

IgM Positivity for Both EBV and CMV: A Clinical Conundrum
por: Jhaveri, Tulip A, et al.
Publicado: (2022)

Monitoring the T-Cell Receptor Repertoire at Single-Clone Resolution
por: Bonarius, Hendrik P.J., et al.
Publicado: (2006)

Coinfection with EBV/CMV and other respiratory agents in children with suspected infectious mononucleosis
por: Wang, Xia, et al.
Publicado: (2010)

The prevalence of CMV and EBV among the patients with the colorectal cancer; a molecular approach
por: Arastefar, Amir, et al.
Publicado: (2015)

Overall avidity declines in TCR repertoires during latent CMV but not EBV infection
por: Couturaud, Barbara, et al.
Publicado: (2023)

S140: IBRUTINIB SENSITIZES CLL CELLS TO VENETOCLAX BY INTERRUPTING TLR9-INDUCED CD40 UPREGULATION AND PROTEIN TRANSLATION
por: Kielbassa, Karoline, et al.
Publicado: (2023)

Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa
por: Adjei, Andrew A, et al.
Publicado: (2008)

Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients
por: Rasmussen, NS, et al.
Publicado: (2015)

Hemophagocytic Lymphohistiocytosis in a Patient With Hodgkin lymphoma and Concurrent EBV, CMV, and Candida Infections
por: Mustafa Ali, Moaath, et al.
Publicado: (2017)

Age and CMV-Infection Jointly Affect the EBV-Specific CD8(+) T-Cell Repertoire
por: Lanfermeijer, Josien, et al.
Publicado: (2021)

Enhanced Costimulatory Signaling Improves CAR T-cell Effector Responses in CLL
por: Collins, McKensie A., et al.
Publicado: (2022)

A Major Subset of Mutated CLL Expresses Affinity-selected and Functionally Proficient Rheumatoid Factors
por: Janssen, Jerry, et al.
Publicado: (2021)

Ibrutinib sensitizes CLL cells to venetoclax by interrupting TLR9-induced CD40 upregulation and protein translation
por: Kielbassa, Karoline, et al.
Publicado: (2023)

Depletion of CLL cells by venetoclax treatment reverses oxidative stress and impaired glycolysis in CD4 T cells
por: van Bruggen, J. A. C., et al.
Publicado: (2022)

Effects of tofacitinib on lymphocyte sub-populations, CMV and EBV viral load in patients with plaque psoriasis
por: Valenzuela, Fernando, et al.
Publicado: (2015)

CMV and EBV targets recognized by tumor-infiltrating B lymphocytes in pancreatic cancer and brain tumors
por: Meng, Qingda, et al.
Publicado: (2018)

Lower CMV and EBV Exposure in Children With Kawasaki Disease Suggests an Under-Challenged Immune System
por: van Stijn, Diana, et al.
Publicado: (2021)

Anti-citrullinated protein antibody response after primary EBV infection in kidney transplant patients
por: Kraal, Lianne J. N., et al.
Publicado: (2018)

Incidence and management of toxicity associated with ibrutinib and idelalisib: a practical approach
por: de Weerdt, Iris, et al.
Publicado: (2017)

Regulation of Bcl-XL by non-canonical NF-κB in the context of CD40-induced drug resistance in CLL
por: Haselager, Marco, et al.
Publicado: (2021)

P620: GENETIC ALTERATIONS AND OUTCOMES WITH FIXED-DURATION IBRUTINIB+VENETOCLAX (IBR+VEN): RESULTS FROM THE PHASE 3 GLOW STUDY IN PATIENTS WITH PREVIOUSLY UNTREATED CLL
por: Kater, Arnon, et al.
Publicado: (2023)

Immune recovery and the risk of CMV/ EBV reactivation in children post allogeneic haematopoietic stem cell transplantation
por: Janeczko, Małgorzata, et al.
Publicado: (2016)

Prevalence and molecular epidemiology of CMV and EBV among nurses working in pediatrics, transplantology, and primary health care
por: Zając, Patrycja W., et al.
Publicado: (2020)

Corrigendum: Lower CMV and EBV Exposure in Children With Kawasaki Disease Suggests an Under-Challenged Immune System
por: van Stijn, Diana, et al.
Publicado: (2021)

Expression of IL‐7Rα and KLRG1 defines functionally distinct CD8(+) T‐cell populations in humans
por: Remmerswaal, Ester B. M., et al.
Publicado: (2019)

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
por: Chatzikonstantinou, Thomas, et al.
Publicado: (2021)

An Unusual Case of CMV/EBV Ventriculoencephalitis with Evolution to Primary Central Nervous System Lymphoma in HIV-Positive Patient
por: Borges, Gisela, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lokflc1nb7jjjpoiiht39go6he